Project Grant R01AI200122
Award Date 7/17/26
Completion Date 6/30/31
Dollars Obligated $653K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98195, USA
Similar Awards
- Federal Grant Award Summary The University of Washington received a $690,538 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective August 19, 2025, through July 31, 2030. This award supports research focused on expanding access to and improving the delivery of tuberculosis preventive therapy (TPT) in Kenya. The project addresses a documented gap between international...
- Federal Grant Award Summary The University of Washington received a $188,760 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective September 1, 2025, through August 31, 2030. This award supports investigator-initiated biomedical research examining interferon gamma (IFNG)-dependent immunity to Mycobacterium tuberculosis (MTB), with focus on how lung macrophages regulate...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Washington $301,826 under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop and evaluate novel therapeutic agents targeting drug-tolerant tuberculosis (TB) persister cells. The research project, which commenced on August 20, 2025, and concludes July 31, 2027, focuses on assessing netupitant (NTP), an FDA-approved antiemetic drug, as a...
- Federal Grant Award Summary The University of Washington received a $445,338 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded on July 23, 2025, with a completion date of June 30, 2027. This award supports research investigating the mechanisms of age-related lung inflammation in pulmonary melioidosis, a frequently fatal tropical infection caused by Burkholderia pseudomallei. The...
- Federal Grant Award Summary Seattle Children's Research Institute received a $859,765 Project Grant awarded July 3, 2026, under the National Institute of Allergy and Infectious Diseases (NIAID) Allergy and Infectious Diseases Research program (CFDA 93.855). The award supports basic and translational biomedical research examining the role of ferroptosis—a form of iron and lipid peroxidation-mediated cell death—in regulating host control of Mycobacterium tuberculosis (MTB) infection. The...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the Board of Regents of the University of Nebraska, through its University of Nebraska Medical Center (UNMC) division, a Project Grant of $422,125 under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award, issued June 8, 2026, with a completion date of May 31, 2028, funds research to develop targeted protein degradation platforms for tuberculosis (TB) drug discovery....
- Federal Project Grant Award Summary Emory University received a $1.17 million Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded September 16, 2025, with completion targeted for August 31, 2030. This research project, conducted at Emory's Atlanta location, focuses on characterizing the infectiousness and social mixing patterns associated with asymptomatic tuberculosis (TB) as a...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the Regents of the University of Minnesota a $757,038 Project Grant effective April 1, 2026, through March 31, 2031, under the Allergy and Infectious Diseases Research program (CFDA 93.855). This award funds research to characterize human airway macrophage immunity in tuberculosis (TB) infection and identify early determinants of Mycobacterium tuberculosis (MTB) control. The primary...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Washington a $209,758 Project Grant on April 17, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to support a Midcareer Investigator Award in Patient-Oriented Research. The award provides protected time for Dr. Paul Drain, MD, MPH, Associate Professor and Director of Clinical Research for the International Clinical Research Center at UW's...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Washington University in St. Louis $427,623 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on February 24, 2026, with a completion date of January 31, 2028. This Project Grant funds research to dissect the impact of HIV-induced immunometabolic perturbation on tuberculosis (TB) control. The research addresses a critical public health gap: people living with HIV...